When is the Best Time to Order GSK’s Arexvy RSV Vaccine?

Table of Contents
A Message from USPPG – A Leading Physician Buying GroupWhy Now the Best Time to Order GSK’s Arexvy RSV Vaccine
As the fall respiratory illness season approaches, physician offices, pharmacies, and other healthcare providers must prepare to meet patient needs—especially when it comes to protecting older adults from RSV (Respiratory Syncytial Virus). At US Physicians’ Purchasing Group (USPPG), we’re here to help our members access vaccines at the best possible pricing through our partnerships with trusted manufacturers and suppliers.
One of the most important vaccines to have on hand this season is Arexvy, the RSV vaccine developed by GSK. With updated CDC recommendations and growing awareness of RSV’s impact on older populations, Arexvy should be a priority in your fall vaccine inventory.
What Is Arexvy?
Arexvy is the first RSV vaccine approved for use in adults. Manufactured by GSK, it is designed to prevent lower respiratory tract disease (LRTD) caused by RSV. According to the FDA and CDC, Arexvy is approved for:
- Adults 60 years of age and older, and
- Adults aged 50 through 59 who are at increased risk of severe RSV disease.
As a physician buying group, USPPG connects practices like yours with exclusive access to discounted pricing on vaccines such as Arexvy—helping you offer more to your patients while keeping costs manageable.
CDC Guidelines: Updated RSV Vaccine Recommendations
In its August 2024 update, the Centers for Disease Control and Prevention (CDC) recommends a single dose of an RSV vaccine for the following:
- Adults 75 and older, regardless of risk level
- Adults aged 50–74 who are at increased risk for severe RSV disease
Currently, revaccination is not recommended, so patients only need to receive one dose.
Risk factors that may qualify patients for vaccination include:
- Chronic lung or respiratory disease
- Chronic cardiovascular disease
- Diabetes with complications or insulin dependency
- Chronic liver disease
- End-stage renal disease or dialysis
- Immunocompromised conditions
- Residency in a long-term care facility
Why Now Is the Right Time to Order Arexvy
1. Fall Is RSV Season
The CDC notes that while Arexvy can be administered any time of year, late summer to early fall is the optimal window to vaccinate. Administering the vaccine just before RSV season ensures maximum protection when the virus is most active—usually between October and March.
By ordering now, your practice can stay ahead of the seasonal surge and avoid potential backorders or supply chain issues.
2. Growing Patient Eligibility Increases Demand
The expanded CDC recommendation now includes adults as young as 50 years old if they are at increased risk. This means:
- More of your patients are eligible than ever before
- Your Arexvy order may need to be larger than last year
- Delaying your purchase could lead to missed opportunities for immunization
3. One-Dose Simplicity
Arexvy is a single-dose vaccine, making it easier to manage than multi-dose series. Patients don’t need to come back for a follow-up, which improves completion rates and reduces administrative burden on your team.
How Physician Buying Groups Like USPPG Support Your Vaccine Program
As a physician buying group, USPPG doesn’t purchase or resell vaccines. Instead, we work on your behalf to negotiate with manufacturers and authorized distributors to help your practice access:
- Discounted pricing on vaccines, including Arexvy
- Easy enrollment with no fees or obligations
- Support and resources for ordering, billing, and administration
Thousands of independent practices across the U.S. have already joined USPPG to simplify vaccine purchasing while improving patient care.
Financial Benefits of Early Arexvy Ordering
✅ Maximize Reimbursement
Arexvy is generally covered by Medicare Part D and private insurers, particularly for those who meet CDC eligibility criteria. By ordering and administering the vaccine early in the season, your practice benefits from timely reimbursement and smooth billing workflows.
✅ Avoid Rush Pricing
Waiting until late fall may limit your options or force you to buy from higher-priced secondary sources. Through USPPG, members can access competitive pricing early, helping protect your bottom line while ensuring vaccine availability.
✅ Improve Practice Efficiency
Advance ordering helps your staff plan appointment schedules, patient outreach, and vaccine inventory with greater confidence and less last-minute scrambling.
FAQ: Arexvy and Your Vaccine Program
Q: Can I administer Arexvy with other fall vaccines like flu or COVID-19?
Yes. Arexvy can be co-administered with other adult vaccines, including flu and COVID-19 vaccines, depending on individual patient health and provider discretion.
Q: Do I have to meet a minimum order size through USPPG?
No. There are no minimum purchase requirements or membership fees. Our role is to give you access to preferred pricing, not to control inventory or mandate volume.
Q: Is training available for my staff on RSV vaccination?
Yes. USPPG provides educational resources to ensure your team understands CDC guidelines and proper administration protocols.
Q: How do I join USPPG?
It’s easy—and free. Simply sign up on our website to gain access to vaccine discounts and ordering instructions. You’ll never be obligated to purchase, and you’ll always maintain full control over your practice’s buying decisions.
Final Thoughts: Secure Arexvy Now for a Strong RSV Season
As a trusted physician buying group, USPPG is committed to helping independent practices and pharmacies navigate vaccine procurement with ease and affordability. With RSV season just around the corner, Arexvy is one of the most important immunizations to stock this year.
If your practice serves adults 50 and older, particularly those with chronic or immunocompromising conditions, now is the time to act. Ordering early allows you to:
- Stay ahead of seasonal demand
- Avoid inventory challenges
- Maximize patient protection
- Optimize insurance reimbursement
Don’t wait—join USPPG today to gain access to exclusive Arexvy pricing and ensure your patients are protected this fall.
RSV Awareness Webinar Series 2025
GSK is launching the RSV Awareness Webinar Series 2025, a weekly educational event running from August 7 through September 15. This timely series is designed to provide healthcare professionals with important information about RSV disease burden in adults, current vaccination options, and CDC recommendations. With RSV season approaching, this program offers a valuable opportunity to ensure your practice is informed and ready.
Each session will be led by GSK Patient Advocates who bring both clinical knowledge and real-world insight to the discussion. The focus of the series will be on how RSV impacts adults—particularly those at increased risk—and how the Arexvy vaccine can help prevent severe lower respiratory tract disease in eligible patient populations. You’ll also receive guidance on identifying at-risk individuals and implementing timely vaccination protocols before the fall season peaks.
This is an ideal opportunity for physicians, practice managers, and vaccine coordinators to stay up-to-date on RSV prevention strategies and strengthen their vaccination programs ahead of the 2025 RSV season. Register now to join the conversation and learn how your practice can help protect vulnerable adult patients this year.
Become a USPPG Member
USPPG is a physician buying group (PBG) that negotiates discounts on vaccines and other medical supplies by leveraging collective purchasing power. We partner with major vaccine manufacturers to secure lower prices and additional benefits.
Key Benefits:
- Membership is Free
- Access to Exclusive Discounts & Rebates
- Significant Cost Savings on Vaccines